MARGETUXIMAB
UNII K911R84KEW

Substance Identification & Data

This profile provides standardized clinical and technical data for Margetuximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) K911R84KEW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1350624-75-7 and the RxNorm Concept ID (RxCUI) 2473851. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

K911R84KEW

CAS Registry Number

1350624-75-7

RxNorm Concept ID

2473851

Detailed Substance Profile

Preferred Name

MARGETUXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

K911R84KEW

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C91733

National Cancer Institute reference terminology for clinical and research data.

INN ID

9799

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-147

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Margetuximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MARGETUXIMAB

MARGETUXIMAB-CMKB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MUS MUSCULUS MONOCLONAL MGAH22 CLONE CH4D5 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MGAH22 CLONE CH4D5 LIGHT CHAIN, DIMER

MARGETUXIMAB [INN]

MARGETUXIMAB [USAN]

MARGETUXIMAB [WHO-DD]

MARGETUXIMAB CMKB [WHO-DD]